![]() |
|
|
M Gellai and RR Ruffolo
The effects of the selective alpha-1 adrenoceptor agonist, cirazoline, and the selective alpha-2 adrenoceptor agonist, B-HT 933, were assessed on renal hemodynamics and on water and solute excretion in conscious, chronically instrumented rats. Infusion (i.v.) of equipressor doses of cirazoline and B-HT 933, 0.04 and 4 mg/kg/hr, respectively, decreased renal plasma flow without changing glomerular filtration rate. Cirazoline infusion did not affect urinary excretion of water, electrolytes or total solutes. In marked contrast, B-HT 933 increased urine flow and sodium excretion significantly (P less than .01) but did not significantly alter potassium and urea excretion. Urine osmolality decreased to hyposmotic levels (from 613 +/- 86 to 172 +/- 8 mOsmol/kg of H2O) during the infusion of B-HT 933, suggesting a possible interaction between the alpha-2 adrenoceptor agonist and the vasopressin system. This diuretic action of the selective alpha-2 adrenoceptor agonist was also observed after the i.v. infusion of a subpressor dose (0.4 mg/kg/hr) of B-HT 933. In rats treated with the ganglionic blocker, hexamethonium (10 mg/kg i.v.), the B-HT 933-induced diuresis was not affected, confirming an action in the periphery, possibly at the level of the kidney. These results suggest that stimulation of renal alpha-2 adrenoceptors in conscious, euvolumic rats modulates the reabsorption of water and sodium at the site of the renal nephron.
This article has been cited by other articles:
![]() |
M. Khalid, N. Ilhami, Y. Giudicelli, and J.-P. Dausse Testosterone Dependence of Salt-Induced Hypertension in Sabra Rats and Role of Renal alpha 2-Adrenoceptor Subtypes J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 43 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Khalid, Y. Giudicelli, and J.-P. Dausse An Up-Regulation of Renal alpha 2A-Adrenoceptors Is Associated with Resistance to Salt-Induced Hypertension in Sabra Rats J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 928 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Plato and J. L. Garvin alpha 2-Adrenergic-mediated tubular NO production inhibits thick ascending limb chloride absorption Am J Physiol Renal Physiol, October 1, 2001; 281(4): F679 - F686. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Plato {alpha}-2 And {beta}-adrenergic receptors mediate NE's biphasic effects on rat thick ascending limb chloride flux Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R979 - R986. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Junaid, L. Cui, S. B. Penner, and D. D. Smyth Regulation of Aquaporin-2 Expression by the alpha 2-Adrenoceptor Agonist Clonidine in the Rat J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 920 - 923. [Abstract] [Full Text] |
||||
![]() |
S. W. Edwards and L. E. Limbird Role for the Third Intracellular Loop in Cell Surface Stabilization of the alpha 2A-Adrenergic Receptor J. Biol. Chem., June 4, 1999; 274(23): 16331 - 16336. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. M. Cabral, D. R. Kapusta, V. A. Kenigs, and K. J. Varner Central alpha 2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1998; 275(6): R1867 - R1874. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Cabral, K. J. Varner, and D. R. Kapusta Renal Excretory Responses Produced by Central Administration of Opioid Agonists in Ketamine and Xylazine-Anesthetized Rats J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 609 - 616. [Abstract] [Full Text] |
||||
![]() |
H. D. Intengan and D. D. Smyth Alpha-2a/d Adrenoceptor Subtype Stimulation by Guanfacine Increases Osmolar Clearance J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 48 - 53. [Abstract] [Full Text] |
||||